v3.26.3
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B Ordinary Shares
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Mar. 11, 2026
Balance (in Shares) at Mar. 11, 2026      
Issuance of class B ordinary shares to sponsor [1] $ 575 24,425 25,000
Issuance of Class B Ordinary Shares to Sponsor, shares [1] 5,750,000      
Net income (loss) (18,761) (18,761)
Balance at Mar. 31, 2026 $ 575 24,425 (18,761) 6,239
Balance (in Shares) at Mar. 31, 2026 5,750,000      
Balance at Mar. 11, 2026
Balance (in Shares) at Mar. 11, 2026      
Net income (loss)         2,003,330
Balance at Sep. 30, 2026 $ 575 (8,858,929) (8,858,354)
Balance (in Shares) at Sep. 30, 2026 5,750,000      
Balance at Mar. 31, 2026 $ 575 24,425 (18,761) 6,239
Balance (in Shares) at Mar. 31, 2026 5,750,000      
Accretion for Class A ordinary shares to redemption amount (9,448,208) (8,756,175) (18,204,383)
Sale of Private Placement Warrants 6,000,000 6,000,000
Fair value of public warrants at issuance 3,450,000 3,450,000
Allocated value of transaction costs to Class A shares (234,967) (234,967)
Fair value of Founder Shares assigned to directors 208,750 208,750
Net income (loss) 107,106 107,106
Balance at Jun. 30, 2026 $ 575 (8,667,830) (8,667,255)
Balance (in Shares) at Jun. 30, 2026 5,750,000      
Accretion for Class A ordinary shares to redemption amount (2,106,084) (2,106,084)
Net income (loss) 1,914,985 1,914,985
Balance at Sep. 30, 2026 $ 575 $ (8,858,929) $ (8,858,354)
Balance (in Shares) at Sep. 30, 2026 5,750,000      
[1] Included an aggregate of up to 750,000 Class B Ordinary Shares that were subject to forfeiture to the extent that the over-allotment option was not exercised in full or in part by the underwriters. On June 8, 2026, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 founder shares are no longer subject to forfeiture (Note 7).